OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 02, 2009
FDA is poised to gain authority and resources to ensure the quality of food and drugs.
Obama's cost-containment and science-innovation initiatives need to overlap.
The financial and economic downturn is likey to have long-term implications for outsourcing.
The role of automation suppliers is transforming to meet the pharma industry's demand for change.
Despite the market downturn, private equity investors are lining up for pharmaceutical services.
April 01, 2009
Despite the market downturn and financial meltdown, private equity investors are lining up for pharmaceutical services businesses.
March 26, 2009
Also, Hospira to reduce workforce; WuXi AppTech makes senior appointments; more...
March 19, 2009
The US Pharmacopeial Convention (USP) and the National Institute for the Control of Pharmaceutical Biological Products (NICPBP), China's agency for overseeing the quality of large- and small-molecule drugs, signed a memorandum of understanding (MOU) to bolster the quality of medicines in China and in the countries that buy Chinese drug products, including the United States.
Also, Genzyme receives warning letter; Mesa Laboratories appoints John J. Sullivan CEO and a member of the board of directors; more...
March 12, 2009
Also, Penn Pharma to expand; stem cell research funding ban lifted; Bristol-Myers Squibb made senior appointments; more...